Clin2
NCT06865755Likely a fitNot yet recruiting

Medication support for breast cancer survivors

Breast Cancer SurvivorBreast Cancer Early Stage Breast Cancer (Stage 1-3)

Part of Cancer clinical trials.

This 6-month study uses a smartphone system to help breast cancer survivors take their endocrine therapy consistently. It's designed for those who have finished active treatment and want support with long-term medication.

Summary written for real people, not researchers, by Clin2.

Phase
N/A
Enrollment
15 people
Ages
21 years to 70 years
Study type
Interventional

Who can take part

  • You speak and read English
  • You are between 21 and 70 years old
  • You were diagnosed with stage 0-3 breast cancer within the last 5 years
  • You have completed all surgery, radiation, and chemotherapy (except endocrine therapy)
  • You are currently taking hormone-blocking pills (endocrine therapy)
  • You do not have a physical condition that makes it hard to use a smartphone system
  • You are willing to use the study's smartphone system for 6 months
  • You have an iPhone or Android phone

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT06781996Recruiting· Phase 3
Digital tool to help manage hormone therapy side effects

This trial tests a digital tool (a smartphone app) to help women and men with early breast cancer manage side effects from hormone therapy. The goal is to improve quality of life during treatment.

Villejuif
NCT06765707Enrolling by invitation
Monitoring symptoms to improve medication use in breast cancer

This trial tests if tracking how you feel and reporting your symptoms can help women with hormone receptor-positive breast cancer take their hormone-blocking medication more consistently. It may be a good fit if you have been prescribed aromatase inhibitors or similar therapy and have had trouble taking it as directed.

Chicago, Illinois
NCT07454499Recruiting
Symptom monitoring and health for women on hormone therapy for breast cancer

This trial tests a mobile health program to help women manage symptoms and stay healthy while taking hormone therapy (like tamoxifen or anastrozole) for early-stage breast cancer. It involves using a smartphone app and an electronic pill bottle to track your health and medication.

Philadelphia, Pennsylvania
NCT07495358Not yet recruiting
Symptom management app for breast cancer chemo patients

This study tests a smartphone-based symptom management system that helps people with breast cancer manage side effects during chemotherapy. It may make it easier for you to track and talk about how you’re feeling.

NCT06729684Recruiting
Digital health program for breast cancer side effects

This study is testing a personalized digital health program to help breast cancer survivors manage side effects. It uses a smartphone app to track symptoms and offer support.

Seoul, Republic of Korea
NCT06726889Recruiting
Improving oral medication adherence in metastatic breast cancer

This study tests a program to help people with metastatic breast cancer take their oral medications as prescribed. It uses a smartphone app to track and support medication adherence, which may improve treatment outcomes.

Milan

Hear when a new Breast Cancer Early Stage Breast Cancer (Stage 1-3) trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.